EIF4A3 and gastric cancer: In summary, EIF4A3-mediated circ_0008126 inhibited gastric cancer proliferation and metastasis in a miR-502-5p- and EIF4A3-dependent manner by attenuating the APC/β-catenin pathway, providing a potential target for the pathogenesis of GC and anti-cancer therapy (Figure 8L).